Table 4.
MRA features
| Hajj-Ali et al., 2002 [1] | Volcy et al., 2004 [5] | McLaren et al., 2005 [6] | Kuker et al., 2008 [7] | Molloy et al., 2008 [8] | Lee et al., 2009 [9] | Pizzanelli et al., 2011 [10] | Kreamer et al., 2011 [11] | Neel et al., 2012 [12] | Pfefferkorn et al., 2012 [13] | Pourmahmoodian et al., 2012 [14] | Coronel-Restrepo et al., 2013 [15] | Cosottini et al., 2014 [16] | Geri et al., 2014 [17] | Oon et al., 2014 [18] | Vera-Lastra et al., 2014 [19] | Salvarani et al., 2015 [20] | Singhal et al., 2016 [21] | Becker et al., 2017 [22] | De Boysson et al., 2017 [23] | Niu et al., 2017 [25] | Schuster et al., 2017 [26] | Peng et al., 2017 [27] | Harsha et al., 2017 [28] | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (n = 16) | (n = 5) | (n = 12) | (n = 16) | (n = 38) | (n = 4) | (n = 8) | (n = 21) | (n = 8) | (n = 4) | (n = 3) | (n = 3) | (n = 8) | (n = 18) | (n = 12) | (n = 12) | (n = 163) | (n = 47) | (n = 25) | (n = 102) | (n = 19) | (n = 31) | (n = 5) | (n = 5) | |
| Performed in | NP* | NP* | NP* | 100% (16) | NP* | 100% (4) | NP* | 81% (17) | 83% (7) | 100% (4) | 33% (1) | 33% (1) | 100% (8) | 39% (7) | 100% (12) | NP* | 79% (129) | 32% (15) | MRA or CT angiography performed in 72% (18) | 89.2% (91) | NP* | 100% (31) | 20% (1) | 100% (5) |
| Abnormal in | 93,5% (15) | 25% [1] | 47,1% [8] |
Abnormal at onset 25% [2] Abnormal at follow-up 50% [4] |
100% [4] | 100% [1] | 100% [1] | 87,5% [7] | 71,4% [5] | 66% [8] | ≥90,4% (103) | NO-specific data | 61% [11] | 62.6% [56] | 51,6% [16] | 0% (0) | 0% (0) | |||||||
| Other findings | Proximal lesions 85,7% [6]; distal lesions 57,1% [4] | Large/proximal vessel vasculitis 65.8% (75); small/distal vessel vasculitis 90.4% (103) |
*NP not performed